EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Using minor variant genomes and machine learning to study the genome biology of SARS-CoV-2 over time

Xiaofeng Dong iD, David A Matthews, Giulia Gallo, Alistair Darby iD, I'ah Donovan-Banfield, Hannah Goldswain, Tracy MacGill, Todd Myers, Robert Orr, Dalan Bailey, Miles W Carroll, Julian A Hiscox iD

Nucleic Acids Research · 2025

DOI: 10.1093/nar/gkaf077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Xiaofeng Dong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, L3 5RF, United K…. Hauptthemen laut MEDLINE: SARS-CoV-2, Genome, Viral, COVID-19, Machine Learning. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Food and Drug Administration, MRC, Medical Countermeasures Initiative contract.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In infected individuals, viruses are present as a population consisting of dominant and minor variant genomes. Most databases contain information on the dominant genome sequence. Since the emergence of SARS-CoV-2 in late 2019, variants have been selected that are more transmissible and capable of partial immune escape. Currently, models for projecting the evolution of SARS-CoV-2 are based on using dominant genome sequences to forecast whether a known mutation will be prevalent in the future. However, novel variants of SARS-CoV-2 (and other viruses) are driven by evolutionary pressure acting on minor variant genomes, which then become dominant and form a potential next wave of infection. In this study, sequencing data from 96 209 patients, sampled over a 3-year period, were used to analyse patterns of minor variant genomes. These data were used to develop unsupervised machine learning clusters to identify amino acids that had a greater potential for mutation than others in the Spike protein. Being able to identify amino acids that may be present in future variants would better inform the design of longer-lived medical countermeasures and allow a risk-based evaluation of viral properties, including assessment of transmissibility and immune escape, thus providing candidates with early warning signals for when a new variant of SARS-CoV-2 emerges.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Genome, ViralCOVID-19Machine LearningHumansSpike Glycoprotein, CoronavirusMutationEvolution, Molecular

Substanzen

Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, L3 5RF, United Kingdom.
  • School of Cellular and Molecular Medicine, University of Bristol, Bristol, BS8 1TD, United Kingdom.
  • The Pirbright Institute, Pirbright, Woking, GU24 0NF, United Kingdom.
  • NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, L69 7BE, Liverpool, United Kingdom.
  • Office of Counterterrorism and Emerging Threats, U.S. Food and Drug Administration, Silver Spring, MD 20993-0002, United States.
  • Wellcome Centre for Human Genetics, Nuffield Department of Medicine, Oxford University, Oxford, OX3 7BN, United Kingdom.

ORCID-Profile: Xiaofeng Dong, Alistair Darby, Julian A Hiscox

Förderung

  • U.S. Food and Drug Administration
  • MRC
  • Medical Countermeasures Initiative contract
  • NIHR Health Protection Research Unit
  • University of Liverpool
  • UK Health Security Agency
  • Liverpool School of Tropical Medicine
  • University of Oxford

Zitieren

APA

Dong, X., Matthews, D. A., Gallo, G., Darby, A., Donovan-Banfield, I., Goldswain, H., MacGill, T., Myers, T., Orr, R., Bailey, D., Carroll, M. W., & Hiscox, J. A. (2025). Using minor variant genomes and machine learning to study the genome biology of SARS-CoV-2 over time. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf077

Vancouver

Dong X, Matthews DA, Gallo G, Darby A, Donovan-Banfield I, Goldswain H, et al. Using minor variant genomes and machine learning to study the genome biology of SARS-CoV-2 over time. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf077

BibTeX
@article{Dong2025,
  author = {Dong, Xiaofeng and Matthews, David A and Gallo, Giulia and Darby, Alistair and Donovan-Banfield, I'ah and Goldswain, Hannah and MacGill, Tracy and Myers, Todd and Orr, Robert and Bailey, Dalan and Carroll, Miles W and Hiscox, Julian A},
  title = {Using minor variant genomes and machine learning to study the genome biology of SARS-CoV-2 over time},
  journal = {Nucleic Acids Research},
  year = {2025},
  doi = {10.1093/nar/gkaf077}
}
Kostenlos starten →